These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy. Thurmond J; Butchbach ME; Palomo M; Pease B; Rao M; Bedell L; Keyvan M; Pai G; Mishra R; Haraldsson M; Andresson T; Bragason G; Thosteinsdottir M; Bjornsson JM; Coovert DD; Burghes AH; Gurney ME; Singh J J Med Chem; 2008 Feb; 51(3):449-69. PubMed ID: 18205293 [TBL] [Abstract][Full Text] [Related]
3. Spinal muscular atrophy: a deficiency in a ubiquitous protein; a motor neuron-specific disease. Monani UR Neuron; 2005 Dec; 48(6):885-96. PubMed ID: 16364894 [TBL] [Abstract][Full Text] [Related]
4. Spinal muscular atrophy: state-of-the-art and therapeutic perspectives. Wirth B Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Jun; 3(2):87-95. PubMed ID: 12215230 [TBL] [Abstract][Full Text] [Related]
5. Identification of a battery of tests for drug candidate evaluation in the SMNDelta7 neonate model of spinal muscular atrophy. El-Khodor BF; Edgar N; Chen A; Winberg ML; Joyce C; Brunner D; Suárez-Fariñas M; Heyes MP Exp Neurol; 2008 Jul; 212(1):29-43. PubMed ID: 18455159 [TBL] [Abstract][Full Text] [Related]
6. High incidence of SMN1 gene deletion in Moroccan adult-onset spinal muscular atrophy patients. Bouhouche A; Benomar A; Birouk N; Bouslam N; Ouazzani R; Yahyaoui M; Chkili T J Neurol; 2003 Oct; 250(10):1209-13. PubMed ID: 14586604 [TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of the spinal muscular atrophy and neuronal apoptosis inhibitory protein genes in Saudi patients with spinal muscular atrophy. Al-Jumah M; Majumdar R; Al-Rajeh S; Awada A; Chaves-Carbello E; Salih M; Al-Shahwan S; Al-Subiey K; Al-Uthaim S Saudi Med J; 2003 Oct; 24(10):1052-4. PubMed ID: 14578966 [TBL] [Abstract][Full Text] [Related]
9. Transmission ratio distortion in the spinal muscular atrophy locus: data from 314 prenatal tests. Botta A; Tacconelli A; Bagni I; Giardina E; Bonifazi E; Pietropolli A; Clementi M; Novelli G Neurology; 2005 Nov; 65(10):1631-5. PubMed ID: 16301493 [TBL] [Abstract][Full Text] [Related]
10. Activation of RNA metabolism-related genes in mouse but not human tissues deficient in SMN. Olaso R; Joshi V; Fernandez J; Roblot N; Courageot S; Bonnefont JP; Melki J Physiol Genomics; 2006 Jan; 24(2):97-104. PubMed ID: 16118268 [TBL] [Abstract][Full Text] [Related]
11. SMN genotypes producing less SMN protein increase susceptibility to and severity of sporadic ALS. Veldink JH; Kalmijn S; Van der Hout AH; Lemmink HH; Groeneveld GJ; Lummen C; Scheffer H; Wokke JH; Van den Berg LH Neurology; 2005 Sep; 65(6):820-5. PubMed ID: 16093455 [TBL] [Abstract][Full Text] [Related]
12. Genetic testing and risk assessment for spinal muscular atrophy (SMA). Ogino S; Wilson RB Hum Genet; 2002 Dec; 111(6):477-500. PubMed ID: 12436240 [TBL] [Abstract][Full Text] [Related]
18. Coinheritance of mutated SMN1 and MECP2 genes in a child with phenotypic features of spinal muscular atrophy (SMA) type II and Rett syndrome. Voutoufianakis S; Psoni S; Vorgia P; Tsekoura F; Kekou K; Traeger-Synodinos J; Kitsiou S; Kanavakis E; Fryssira H Eur J Paediatr Neurol; 2007 Jul; 11(4):235-9. PubMed ID: 17276711 [TBL] [Abstract][Full Text] [Related]